These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8147933)

  • 1. Effect of low-dose cyclosporin A on systemic lupus erythematosus disease activity.
    Tokuda M; Kurata N; Mizoguchi A; Inoh M; Seto K; Kinashi M; Takahara J
    Arthritis Rheum; 1994 Apr; 37(4):551-8. PubMed ID: 8147933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of 1 year cyclosporine A treatment on the activity and renal involvement of systemic lupus erythematosus: a pilot study.
    Dostál C; Tesar V; Rychlík I; Zabka J; Vencovský J; Bartûnková J; Stejskalová A; Tegzova D
    Lupus; 1998; 7(1):29-36. PubMed ID: 9493146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term treatment of systemic lupus erythematosus with cyclosporin A.
    Caccavo D; Laganà B; Mitterhofer AP; Ferri GM; Afeltra A; Amoroso A; Bonomo L
    Arthritis Rheum; 1997 Jan; 40(1):27-35. PubMed ID: 9008597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclosporine A in the long-term management of systemic lupus erythematosus.
    Germano V; Picchianti Diamanti A; Ferlito C; Podestà E; Salemi S; Migliore A; D' Amelio R; Laganà B
    J Biol Regul Homeost Agents; 2011; 25(3):397-403. PubMed ID: 22023764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of cyclosporine A in patients with refractory systemic lupus erythematosus in a daily clinical practice.
    Ogawa H; Kameda H; Amano K; Takeuchi T
    Lupus; 2010 Feb; 19(2):162-9. PubMed ID: 19952069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclosporin A in the treatment of systemic lupus erythematosus: results of an open clinical study.
    Manger K; Kalden JR; Manger B
    Br J Rheumatol; 1996 Jul; 35(7):669-75. PubMed ID: 8670602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective study of low-dose cyclosporine A in patients with refractory lupus nephritis.
    Ogawa H; Kameda H; Nagasawa H; Sekiguchi N; Takei H; Tsuzaka K; Amano K; Takeuchi T
    Mod Rheumatol; 2007; 17(2):92-7. PubMed ID: 17437162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of pure red cell aplasia in systemic lupus erythematosus with cyclosporin A.
    Atzeni F; Sarzi-Puttini P; Capsoni F; Vulpio L; Carrabba M
    Clin Exp Rheumatol; 2003; 21(6):759-62. PubMed ID: 14740456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic drug monitoring of cyclosporine microemulsion in patients with corticosteroid-resistant systemic lupus erythematosus.
    Wada Y; Kotani T; Takeuchi T; Wakura R; Wakura D; Makino S; Hanafusa T
    Mod Rheumatol; 2015 Sep; 25(5):708-13. PubMed ID: 25835315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An audit of cyclosporin for systemic lupus erythematosus and related overlap syndromes: limitations of its use.
    Morton SJ; Powell RJ
    Ann Rheum Dis; 2000 Jun; 59(6):487-9. PubMed ID: 10834868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The chronic damage in systemic lupus erythematosus is driven by flares, glucocorticoids and antiphospholipid antibodies: results from a monocentric cohort.
    Conti F; Ceccarelli F; Perricone C; Leccese I; Massaro L; Pacucci VA; Truglia S; Miranda F; Spinelli FR; Alessandri C; Valesini G
    Lupus; 2016 Jun; 25(7):719-26. PubMed ID: 26821965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessments of fatigue and disease activity in patients with systemic lupus erythematosus enrolled in the Phase 2 clinical trial with blisibimod.
    Petri MA; Martin RS; Scheinberg MA; Furie RA
    Lupus; 2017 Jan; 26(1):27-37. PubMed ID: 27353505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeated administration of dapirolizumab pegol in a randomised phase I study is well tolerated and accompanied by improvements in several composite measures of systemic lupus erythematosus disease activity and changes in whole blood transcriptomic profiles.
    Chamberlain C; Colman PJ; Ranger AM; Burkly LC; Johnston GI; Otoul C; Stach C; Zamacona M; Dörner T; Urowitz M; Hiepe F
    Ann Rheum Dis; 2017 Nov; 76(11):1837-1844. PubMed ID: 28780512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of prasterone on disease activity and symptoms in women with active systemic lupus erythematosus.
    Petri MA; Mease PJ; Merrill JT; Lahita RG; Iannini MJ; Yocum DE; Ginzler EM; Katz RS; Gluck OS; Genovese MC; Van Vollenhoven R; Kalunian KC; Manzi S; Greenwald MW; Buyon JP; Olsen NJ; Schiff MH; Kavanaugh AF; Caldwell JR; Ramsey-Goldman R; St Clair EW; Goldman AL; Egan RM; Polisson RP; Moder KG; Rothfield NF; Spencer RT; Hobbs K; Fessler BJ; Calabrese LH; Moreland LW; Cohen SB; Quarles BJ; Strand V; Gurwith M; Schwartz KE
    Arthritis Rheum; 2004 Sep; 50(9):2858-68. PubMed ID: 15452837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic lupus erythematosus with refractory hemolytic anemia effectively treated with cyclosporin A: a case report.
    Wang SW; Cheng TT
    Lupus; 2005; 14(6):483-5. PubMed ID: 16038113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I, randomized, double-blind, placebo-controlled, multiple intravenous, dose-ascending study of sirukumab in cutaneous or systemic lupus erythematosus.
    Szepietowski JC; Nilganuwong S; Wozniacka A; Kuhn A; Nyberg F; van Vollenhoven RF; Bengtsson AA; Reich A; de Vries DE; van Hartingsveldt B; Robinson DW; Gordon R; Hsu B
    Arthritis Rheum; 2013 Oct; 65(10):2661-71. PubMed ID: 23896980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical experiences with cyclosporin A in patients with systemic lupus erythematosus].
    Tarr T; Zeher M; Szegedi G; Kiss E
    Orv Hetil; 2005 Dec; 146(49):2485-9. PubMed ID: 16398313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low dose cyclosporine A in the treatment of resistant proliferative lupus nephritis.
    Sheikholeslami M; Hajialilo M; Rasi Hashemi SS; Malek Mahdavi A; Gojazadeh M; Khabbazi A
    Mod Rheumatol; 2018 May; 28(3):523-529. PubMed ID: 28753077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporine for the treatment of lupus nephritis in patients with systemic lupus erythematosus.
    Yang TH; Wu TH; Chang YL; Liao HT; Hsu CC; Tsai CY; Chou YC
    Clin Nephrol; 2018 Apr; 89(4):277-285. PubMed ID: 29319493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclosporin A in a pregnant patient affected with systemic lupus erythematosus.
    Doria A; Di Lenardo L; Vario S; Calligaro A; Vaccaro E; Gambari PF
    Rheumatol Int; 1992; 12(2):77-8. PubMed ID: 1411086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.